pharma · Chronic Hepatitis Delta Virus Infection · Advanced or Unresectable Hepatocellular Carcinoma (HCC)
Huahui Health
Huahui Health trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Changping, CN HQ
3 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Changping, CN
- Employees
- 3
- Programs
- 2
- Drugs
- 2
- Patents
- 0
Huahui Health clinical trials
Registry index of 2 ClinicalTrials.gov studies linked to Huahui Health programs — each row shows trial ID, program name, phase, status, and indication.
Huahui Health trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Huahui Health.
Trial registry
-
CT.gov ↗ - NCT07547553CT.gov ↗
Will receive HH-009 injection 20 mg/kg, Q3W
Advanced or Unresectable Hepatocellular Carcinoma (HCC)